Experts wrapped up the 2024 San Antonio Breast Cancer Symposium® by discussing updates from the week that may have an immediate impact for patients and physicians.

Neil Vasan, MD, PhD; Pedram Razavi, MD, PhD; Janice Tsang, MBBS, MRCP, FRCP; and Michael A. Danso, MD, highlighted recent developments across breast cancer research and care.

Panelists discussed recent U.S. Food and Drug Administration approvals, plus the importance of monitoring ovarian toxicity in breast cancer clinical trials.

Presenters focused on the mechanisms linking obesity to breast cancer risk and discussed modifiable factors such as body weight, dietary patterns, and physical activity.